Patient Guide: A Study to Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 13 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04303858
Status: ACTIVE_NOT_RECRUITING
Condition: Solid Tumors
Phase: PHASE1

Where You Can Participate

This study is available at 13 locations across the country.

Top locations include:
  • • Brussels,
  • • Leuven,
  • • Herlev,
  • • And 10 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors - Join Clinical Trial NCTNCT04303858

How to Join This Clinical Trial - NCTNCT04303858

Learn how to participate in this PHASE1 trial studying an investigational therapy for Solid Tumors. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Solid Tumors. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Solid Tumors
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04303858 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 13 locations. Find a study site near you:

Clinical Research Site

Brussels, 1200 - Belgium

Status: Contact for availability

Clinical Research Site

Leuven, 3000 - Belgium

Status: Contact for availability

Clinical Research Site

Herlev, 2730 - Denmark

Status: Contact for availability

Clinical Research Site

København Ø, 2100 - Denmark

Status: Contact for availability

Clinical Research Site

Amsterdam, 1066 CX - Netherlands

Status: Contact for availability

Clinical Research Site

Rotterdam, 3015 GD - Netherlands

Status: Contact for availability

Clinical Research Site

Gda?sk, 80-214 - Poland

Status: Contact for availability

Clinical Research Site

Warsaw, 02-781 - Poland

Status: Contact for availability

Clinical Research Site

Pamplona, Navarre 31008 - Spain

Status: Contact for availability

Clinical Research Site

Barcelona, 08003 - Spain

Status: Contact for availability

And 3 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Solid Tumors:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships